Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonino Carlo Privitera

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Digestive Diseases (Basel, Switzerland)|February 20, 2025
STW 5-II for Treatment of Functional Gastrointestinal Disorders: Mechanism and Clinical EfficacyAntonio Tursi, Beatrice Marinoni, Antonino Carlo Privitera, et al.
Chirurgia Italiana|August 22, 2009
Biofeedback therapy for outlet dysfunction: our experienceAntonino Carlo Privitera, Conchita Emanuela Oliveri, Giuseppe Randazzo, et al.
Chirurgia Italiana|August 22, 2009
Parastomal hernia repair with the use of Parietex composite mesh: a technical noteLino Succi, Nnawuihe Luca Ohazuruike, Conchita Emanuela Oliveri, et al.
Chirurgia Italiana|October 8, 2008
Treatment strategies for chronic constipation: our experienceLino Succi, Conchita Emanuela Oliveri, Antonino Carlo Privitera, et al.
Chirurgia Italiana|June 20, 2009
Biofeedback therapy for faecal incontinence: our experienceAntonino Carlo Privitera, Conchita Emanuela Oliveri, Giuseppe Randazzo, et al.
Chirurgia Italiana|April 28, 2009
Perineal hernia: a case of outlet dysfunctionLino Succi, Nnawuihe Luca Ohazuruike, Conchita Emanuela Oliveri, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 24, 2017
Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter studyAnna Viola, Giuseppe Costantino, Antonino Carlo Privitera, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's diseaseFabio Salvatore Macaluso, Mauro Grova, Marica Saladino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2018
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseasesFabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, et al.
United European Gastroenterology Journal|August 11, 2020
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre studyFabio Salvatore Macaluso, Walter Fries, Sara Renna, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Digestive Diseases (Basel, Switzerland)|February 20, 2025
STW 5-II for Treatment of Functional Gastrointestinal Disorders: Mechanism and Clinical EfficacyAntonio Tursi, Beatrice Marinoni, Antonino Carlo Privitera, et al.
Chirurgia Italiana|August 22, 2009
Biofeedback therapy for outlet dysfunction: our experienceAntonino Carlo Privitera, Conchita Emanuela Oliveri, Giuseppe Randazzo, et al.
Chirurgia Italiana|August 22, 2009
Parastomal hernia repair with the use of Parietex composite mesh: a technical noteLino Succi, Nnawuihe Luca Ohazuruike, Conchita Emanuela Oliveri, et al.
Chirurgia Italiana|October 8, 2008
Treatment strategies for chronic constipation: our experienceLino Succi, Conchita Emanuela Oliveri, Antonino Carlo Privitera, et al.
Chirurgia Italiana|June 20, 2009
Biofeedback therapy for faecal incontinence: our experienceAntonino Carlo Privitera, Conchita Emanuela Oliveri, Giuseppe Randazzo, et al.
Chirurgia Italiana|April 28, 2009
Perineal hernia: a case of outlet dysfunctionLino Succi, Nnawuihe Luca Ohazuruike, Conchita Emanuela Oliveri, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|May 24, 2017
Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter studyAnna Viola, Giuseppe Costantino, Antonino Carlo Privitera, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2022
The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's diseaseFabio Salvatore Macaluso, Mauro Grova, Marica Saladino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 27, 2018
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseasesFabio Salvatore Macaluso, Rosalba Orlando, Walter Fries, et al.
United European Gastroenterology Journal|August 11, 2020
Effectiveness and safety of vedolizumab in biologically naïve patients: A real-world multi-centre studyFabio Salvatore Macaluso, Walter Fries, Sara Renna, et al.
Pageof 3